Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The training of clinical neurology trainees is an extensive process that requires mastery of core medical sciences alongside the integration of evidence-based clinical practice (EBCP). However, education in neurology and neurosurgery has not kept pace with the growing emphasis on EBCP across various medical specialties.

Objective: This review aims to evaluate the effectiveness of innovative training methods in enhancing the teaching and application of evidence-based neurology (EBN) among clinical neurology trainees.

Methods: The review explores the implementation of innovative training methods, including the flipped classroom model and AI-based tools, to develop trainees' critical appraisal skills and deepen their understanding of clinical evidence. The proposed EBN curriculum focuses on contemporary clinical questions and utilises state-of-the-art technologies to improve diagnostic accuracy and treatment outcomes in neurology.

Results: Structured topic selection, preparation, and tutorial sessions are designed to enhance practical knowledge and critical evaluation skills. The integration of AI tools supports trainees in conducting comprehensive literature searches and critically appraising studies.

Conclusion: This dynamic approach ensures that neurology training remains responsive to the evolving needs of the field, ultimately leading to superior patient care based on the best available evidence.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jep.70224DOI Listing

Publication Analysis

Top Keywords

evidence-based neurology
8
clinical neurology
8
innovative training
8
training methods
8
neurology
6
training
5
clinical
5
innovative approaches
4
approaches training
4
training evidence-based
4

Similar Publications

Introduction: Refractory migraine (RM) is characterized by a lack of response to both migraine-specific and repurposed treatments, significantly impairing quality of life. Risk factors for RM include, among others, overuse of symptomatic medications, nonadherence to treatment and comorbid conditions that limit the use of anti-migraine medications.

Areas Covered: This critical perspective addresses the diagnosis and management of patients with RM.

View Article and Find Full Text PDF

Introduction: Carers of people with non-memory-led dementias such as posterior cortical atrophy (PCA), primary progressive aphasia (PPA) and behavioural variant frontotemporal dementia (bvFTD) face unique challenges. Yet, little evidence-based support and guidance are available for this population. To address this gap in services, we have developed a novel, web-based educational programme: the Better Living with Non-memory-led Dementia programme (BELIDE).

View Article and Find Full Text PDF

Background: Sunlight offers significant health benefits; however, its therapeutic use among yoga and naturopathy physicians varies across India owing to differences in state regulations and training patterns. This study aimed to establish consensus-based guidelines for therapeutic sunbathing using the Delphi method.

Methods: This three-round Delphi study enrolled 25 yoga and naturopathy physicians, after obtaining ethical approval and informed consent.

View Article and Find Full Text PDF

Background: Radiologically Isolated Syndrome (RIS) is defined as incidentally found MRI abnormalities that are radiographically indistinguishable from multiple sclerosis (MS) and is considered a presymptomatic disease state of MS. Age <37 years, infratentorial or spinal cord lesions, gadolinium-enhancing lesions on index imaging, and positive cerebrospinal fluid oligoclonal bands have been identified as risk factors for conversion to MS. There are no existing guidelines regarding the role of disease-modifying therapy (DMT) in RIS patients.

View Article and Find Full Text PDF

Approximately 400 million individuals globally are estimated to suffer from Long COVID, an infection-associated chronic condition that occurs after SARS-CoV-2 infection. Despite the high burden, there are no evidence-based or FDA-approved interventions to treat the condition. Given its complexity, a multicomponent approach grounded in a whole-person health model is likely required.

View Article and Find Full Text PDF